Streetbeat News

Stock Prices

OLLI

Ollie's Bargain Outlet Holdings, Inc. (NASDAQ:OLLI) reported higher than expected earnings for Q3, with a 14.8% Y/Y sales increase to $480.05 million and adjusted EPS of 51 cents, surpassing the consensus of 44 cents. The company raised its FY23 net sales and adjusted EPS outlook, but shares fell 3.1% following the announcement. UBS and RBC Capital increased their price targets on OLLI, maintaining Neutral and Outperform ratings respectively.

Portfolio Pulse from Avi Kapoor

December 07, 2023 | 5:48 pm

DISH

SATS

EchoStar Corporation's stock is trading higher following the FCC's approval for the transfer of control of Dish Network and its subsidiaries to EchoStar. This regulatory approval is a significant step in the consolidation process between the two entities, potentially leading to operational synergies and a more streamlined corporate structure.

Portfolio Pulse from Benzinga Newsdesk

December 07, 2023 | 5:47 pm

TOL

Toll Brothers, Inc. (NYSE:TOL) exceeded Q4 earnings expectations with $4.11 per share against estimates of $3.71 and reported sales of $3.02 billion, surpassing the $2.77 billion forecast. The company anticipates 1,800-1,900 deliveries in Q1 and 9,850-10,350 for FY24. Post-earnings, TOL shares rose 2.6% to $91.23. Analysts from Barclays, Goldman Sachs, UBS, and RBC Capital revised their price targets for TOL, with UBS setting the highest target at $112.

Portfolio Pulse from Avi Kapoor

December 07, 2023 | 5:42 pm

GOOG

GOOGL

MSFT

NVDA

Wedbush analyst Dan Ives praised Microsoft CEO Satya Nadella and Nvidia CEO Jensen Huang as leaders in the AI revolution. Ives is bullish on Microsoft's prospects for 2024, especially after the company's involvement with OpenAI and the return of Sam Altman as OpenAI's CEO. Microsoft has integrated OpenAI's GPT-4 and Dall-E 3 into its services, while Google has launched its AI model Gemini, which competes with OpenAI's GPT-4.

Portfolio Pulse from Rounak Jain

December 07, 2023 | 5:40 pm

CCG

CNFRZ

FANH

FGFPP

HIPO

HUIZ

IGIC

MHLA

MHLD

MRAI

TIRX

WDH

In Thursday's intraday session, insurance stocks saw movement with Marpai, Huize Holding, Tian Ruixiang Holdings, Fanhua, Maiden Hldgs, and Intl General Insurance recording gains, while Conifer Holdings, FG Finl Gr, Waterdrop, Maiden Holdings Ltd. Notes, Cheche Group, and Hippo Holdings experienced losses. Notably, Waterdrop's Q3 earnings were released.

Portfolio Pulse from Benzinga Insights

December 07, 2023 | 5:40 pm

BMY

Bristol Myers Squibb (NYSE:BMY) shares rose after announcing positive Phase 3 trial results for Opdivo plus Yervoy in treating MSI-H/dMMR metastatic colorectal cancer. The trial met its primary endpoint of progression-free survival. The safety profile was consistent with prior data, with no new safety concerns. The study continues to assess other endpoints. Additionally, the FDA accepted a supplemental application for Opdivo with chemotherapy for urothelial carcinoma, granting Priority Review with a goal date of April 5, 2024.

Portfolio Pulse from Vandana Singh

December 07, 2023 | 5:37 pm

VEEV

Veeva Systems Inc. (NYSE:VEEV) reported Q3 earnings with a 12% Y/Y revenue increase to $616.5 million, surpassing the consensus of $615.98 million. Adjusted EPS was $1.34, beating the $1.30 consensus. However, the company lowered Q4 revenue guidance to $620-$622 million, below the consensus of $623.18 million, with an adjusted EPS forecast of $1.30, slightly above the $1.28 estimate. Following the earnings report, VEEV shares dropped 2.5%. Analysts from Canaccord Genuity, Barclays, Needham, and Piper Sandler adjusted their price targets and ratings for VEEV.

Portfolio Pulse from Avi Kapoor

December 07, 2023 | 5:35 pm

ABNB

AMZN

BABA

LEN

LULU

MCD

NIO

TSLA

WYNN

ZUMZ

Today's whale activity in the consumer discretionary sector shows significant options trading, with bullish, bearish, and neutral sentiments across various stocks. Notable trades include bullish call options for TSLA, AMZN, WYNN, and LEN, bearish call options for NIO, bearish put options for MCD, ZUMZ, ABNB, and BABA, and neutral call options for LULU. The trades involve varying expiration dates, strike prices, and total trade prices, indicating diverse expectations from the whales.

Portfolio Pulse from Benzinga Insights

December 07, 2023 | 5:35 pm

JNJ

SNY

VNDA

Vanda Pharmaceuticals Inc (VNDA) has acquired the U.S. and Canadian rights to the multiple sclerosis drug Ponvory from Actelion Pharmaceuticals, a Johnson & Johnson (JNJ) company. The drug is FDA and Health Canada approved for treating relapsing forms of multiple sclerosis (RMS). Vanda paid $100 million for the rights, and Janssen will continue to operate under a Transitional Business License Agreement. Ponvory has shown superiority to Sanofi SA's (SNY) Aubagio in clinical studies. VNDA shares dropped 3.05% to $3.92.

Portfolio Pulse from Vandana Singh

December 07, 2023 | 5:32 pm

BNED

FTEL

GDHG

SPWH

In Thursday's intraday session, several consumer discretionary stocks experienced significant movements. Fitell's shares surged by 44.9%, while Barnes & Noble Education rose by 25.71% following their Q2 earnings release. Kaival Brands Innovations, Fossil Group, China Liberal Education, and Esports Entertainment also saw gains. Conversely, Golden Heaven Group Holdings plummeted by 72.1%, and other stocks like Harbor Custom Development, Foresight Autonomous, Sportsman's Warehouse, 17 Education & Technology, and Nogin faced declines, with some reacting to their Q3 earnings reports.

Portfolio Pulse from Benzinga Insights

December 07, 2023 | 5:31 pm